Abstract. Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-associated mortality worldwide, particularly in China. MicroRNAs (miRs) serve important roles in the pathogenesis of HCC. The present study investigated the function of miR-1271 in HCC. The miR-1271 levels were analyzed by quantitative reverse transcription polymerase chain reaction. Cells growth was examined by MTT assay. Bioinformatics algorithms from TargetScanHuman were used to predict the target genes of miR-1271. The protein level was assayed by western blotting. miR-1271 demonstrated a lower expression level in HCC tissues. Upregulation of miR-1271 suppressed the growth of HepG-2 and Huh-7 cells and induced apoptosis of cells. Forkhead box Q1 (FOXQ1) was targeted by miR-1271. In conclusion, miR-1271 is a novel tumor suppressor that inhibits HCC proliferation and induces cellular apoptosis by targeting FOXQ1 in HCC. The results of the present study may provide a novel therapeutic target of HCC.
IntroductionHepatocellular carcinoma (HCC) accounts for ~80% of all liver cancer cases, and is one of the most common causes of cancer-associated mortality worldwide (1,2). The prevalence rate of HCC in China is particularly high, but continues to increase in numerous western countries (1,3). Despite HCC being was one of the first cancers to be linked epidemiologically to a definite risk factor, the underlying mechanisms of HCC pathogenesis remain unclear (4). The risk factors for HCC vary by location. In China, Hepatitis B or Hepatitis C virus infections are the main risk factors (5). The survival rate of patients with HCC has been extended due to progress in liver transplantation and other treatments; however, the insensitivity of chemotherapeutic drugs, cancer recurrence and metastasis continue to contribute to a poor prognosis (6). Thus, the identification of therapeutic targets and translation of molecular studies of HCC into clinical practice is urgently required.MicroRNAs (miRNAs) are a class of small non-coding RNAs, which are ~22 nucleotides in length (7-9). A number of miRNAs have been revealed to be involved in the pathogenesis of HCC (10-26). The roles of miR-1271 in numerous types of cancers have previously been investigated. For example, in gastric cancer, miR-1271 inhibited cell proliferation, invasion and epithelial-mesenchymal transition (EMT) by targeting forkhead box Q1 (FOXQ1) (27). Additionally, in oral squamous cell carcinoma, miR-1271 inhibited cell growth and metastasis by targeting anaplastic lymphoma receptor tyrosine kinase (28). In HCC, a previous study demonstrated that miR-96, miR-129-1-3p, miR-1291, miR-1303 and miR-1271 differentially regulated Glypican-3 (GPC3) expression levels in HCC cells and that the upregulation of GPC3 was associated with a concomitant downregulation of its repressor miR-1271 (29). However, the roles served by miR-1271 in HCC remain unclear.The present study analyzed the expression level of miR-1271 in HCC tissues and determined the in vitro function of miR-1271. The aim of the ...